Conversion of recurrent delta-positive hepatitis B infection to seronegativity with famciclovir after liver transplantation

Transplantation

Volumn 64, Issue 1, 1997, Pages 162-163

  Klein, Michael ^a,b   Geoghegan, Justin ^a   Schmidt, Karl ^a   Böckler, Dittmar ^a   Korn, Klaus ^c   Wittekind, Christian ^d   Scheele, Johannes ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b JENA UNIVERSITY HOSPITAL   (Germany)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FAMCICLOVIR; PROSTAGLANDIN E1;

ADULT; ANTIBODY TITER; ARTICLE; CASE REPORT; DELTA AGENT HEPATITIS; GRAFT SURVIVAL; HEPATITIS B; HUMAN; LIVER TRANSPLANTATION; MALE; ORAL DRUG ADMINISTRATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RECURRENT INFECTION;

EID: 0030838348     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199707150-00028     Document Type: Article

References (7)

1. Sinclair S, Greig P, Blendis L, et al. Biochemical and clinical response of fulminant viral hepatitis to administration of prostaglandin E: a preliminary report. J Clin Invest 1989; 84: 1063.
2. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Engl J Med 1993; 329: 1842.
3. Samuel D Bismuth A, Mathieu D, et al. Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. Lancet 1991; 337: 813.
4. Todo S Demetris AJ, Van Thiel D, et al. Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology 1991; 13: 619.
5. McMillan JS, Shaw T, Angus PW, Locarnini SA. Effect of immunosuppressive and antiviral agents on hepatitis B virus replication in vitro. Hepatology 1995; 22: 36.
6. Böker KH, Ringe B, Krüger M, et al. Prostaglandin E plus famciclovir: a new concept for the treatment of severe hepatitis B after liver transplantation. Transplantation 1994; 57: 1706.
7. Krogsgaard K, Kryger P, Aldershvile J, et al. Delta infection and suppression of hepatitis B virus replication in chronic HBsAg carriers. Hepatology 1987; 7: 42.